Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - amiloride hydrochloride - oral tablet - 5mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

stat rx usa llc - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride 500 mg - metformin hydrochloride tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. metformin hydrochloride extended-release tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. metformin hydrochloride tablets and metformin hydrochloride extended-release tablets are contraindicated in patients with: - renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels ≥1.5 mg/dl [males], ≥1.4 mg/dl [females] or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia (see warnings and precautions). - known hypersensitivity to metformin hydrochloride. - acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin. metformin hydrochloride tablets and metformin hydrochloride

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

cardinal health - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride 500 mg - metformin hydrochloride tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. metformin hydrochloride extended-release tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. metformin hydrochloride tablets and metformin hydrochloride extended-release tablets are contraindicated in patients with: metformin hydrochloride tablets and metformin hydrochloride extended-release tablets should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function (see also precautions ).

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiloride hydrochloride dihydrate 5mg;  ; hydrochlorothiazide 50mg - tablet - 50mg/5mg - active: amiloride hydrochloride dihydrate 5mg   hydrochlorothiazide 50mg excipient: calcium hydrogen phosphate guar gum lactose magnesium stearate maize starch pregelatinised maize starch sunset yellow fcf - moduretic is indicated in the treatment of patients with: - oedema of cardiac origin; - hepatic cirrhosis with ascites; - hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of an excessive drop in blood pressure.

Namiibia - inglise - Namibia Medicines Regulatory Council

specpharm (pty) ltd - amiloride hcl; hydrochlorothiazide - tablet - each tablet contains amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide, quantity: 40 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; maize starch; sunset yellow fcf; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc - frumil is indicated for the treatment of cardiac failure, in patients who require diuretics plus potassium supplements, or potassium sparing diuretics.

Malta - inglise - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - amiloride hydrochloride - oral solution - amiloride hydrochloride 5.675 mg - diuretics

Malta - inglise - Medicines Authority

wockhardt uk limited - amiloride hydrochloride; furosemide - tablet - amiloride hydrochloride; furosemide - diuretics

Malta - inglise - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - amiloride hydrochloride, hydrochlorothiazide - tablet - amiloride hydrochloride 5 mg hydrochlorothiazide 50 mg - diuretics

Malta - inglise - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - amiloride hydrochloride, furosemide - tablet - amiloride hydrochloride 5.68 mg furosemide 40 mg - diuretics